Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Shares Issued (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Shares Issued for 7 consecutive years, with -$122000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 94.34% to -$122000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.8 million for FY2025, N/A changed from the prior year.
  • Shares Issued for Q4 2025 was -$122000.0 at Beam Therapeutics, down from $412000.0 in the prior quarter.
  • The five-year high for Shares Issued was $260.0 million in Q1 2021, with the low at -$255.0 million in Q2 2021.
  • Average Shares Issued over 5 years is $2.5 million, with a median of $1.1 million recorded in 2023.
  • The sharpest move saw Shares Issued crashed 70945.83% in 2021, then surged 3056900.0% in 2023.
  • Over 5 years, Shares Issued stood at $2.0 million in 2021, then plummeted by 100.05% to -$1000.0 in 2022, then soared by 3056900.0% to $30.6 million in 2023, then plummeted by 107.05% to -$2.2 million in 2024, then surged by 94.34% to -$122000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$122000.0, $412000.0, and $973000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.